4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-21-000279
Chairman, CEO & President sold 3,000 shares at an average $535.97 ($1,607,899)
From the SEC's structured data for this filing
Trades in this filing
SAYER KEVIN R · Chairman, CEO & President
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-15 | Sale : show line 1 in the form | −200 | $528.06 | $105,613 | 84,505 | D |
| 2021-12-15 | Sale : show line 2 in the form | −148 | $529.78 | $78,407 | 84,357 | D |
| 2021-12-15 | Sale : show line 3 in the form | −25 | $530.44 | $13,261 | 84,332 | D |
| 2021-12-15 | Sale : show line 4 in the form | −300 | $531.87 | $159,560 | 84,032 | D |
| 2021-12-15 | Sale : show line 5 in the form | −100 | $532.92 | $53,292 | 83,932 | D |
| 2021-12-15 | Sale : show line 6 in the form | −500 | $534.84 | $267,422 | 83,432 | D |
| 2021-12-15 | Sale : show line 7 in the form | −250 | $536.01 | $134,002 | 83,182 | D |
| 2021-12-15 | Sale : show line 8 in the form | −271 | $537.08 | $145,548 | 82,911 | D |
| Open-market sales · 3,000 sh · avg $535.97 · $1,607,899 | ||||||
Loading xslF345X03/edgardoc.xml…